The Online Investor
Cangene Corp. (CNJ.CA)

Cangene is a biopharmaceutical company in the business of developing, manufacturing and commercializing products and technologies for global markets.Co. is focused primarily on developing and manufacturing therapeutics for infectious diseases or biodefence applications. Co. has two different types of products: plasma products and in particular hyperimmunes, which are concentrated specialty antibody preparations made from specialty plasma; and recombinant biopharmaceuticals, which are therapeutic proteins made by introducing a particular gene into a host organism, which in turn produces the protein of interest.
Company Name: 
Cangene Corp.
Quotes delayed 20 minutes

Email EnvelopeFree CNJ.CA Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Cangene Corp. (CNJ.CA) Page | The Online Investor Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.